button bars forest bayes pooled summary circles
 
deaths (OS)

mUC - L2 - PDL1 positive metastatic/advanced UC (mUC) - 2nd Line (L2) mUC - L2 - PDL1 positive

versus Standard of Care (SoC)
atezolizumab alone vs. Standard of Care (SoC) 2 certainty unassessable-12%
pembrolizumab alone vs. Standard of Care (SoC) 1 certainty unassessablestatistically conclusive-40%

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons